Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISEREDE FYSIOTERAPEUTER LANGÅ SUNDHEDSCENTER APS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   10.5% 10.6% 7.1% 3.8% 5.5% 2.1% 7.2% 7.2%   Credit score (0-100)   25 24 34 49 41 66 33 33   Credit rating   BB BB BBB BBB BBB A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   538 636 771 505 856 2,056 0.0 0.0   EBITDA   75.5 73.3 138 -68.6 -65.9 858 0.0 0.0   EBIT   32.5 5.0 82.2 -92.4 -374 526 0.0 0.0   Pre-tax profit (PTP)   25.9 2.8 81.3 -188.0 -568.1 263.7 0.0 0.0   Net earnings   18.2 1.7 64.4 -148.7 -607.9 263.7 0.0 0.0   Pre-tax profit without non-rec. items   25.9 2.8 81.3 -188 -568 264 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   31.7 17.9 44.7 1,020 1,146 1,044 0.0 0.0   Shareholders equity total   82.9 84.5 114 -34.3 -242 21.4 -76.6 -76.6   Interest-bearing liabilities   2.3 6.7 4.1 2,932 3,302 3,327 2,277 2,277   Balance sheet total (assets)   185 146 267 3,771 3,695 3,471 2,200 2,200   Net Debt   -42.1 -36.3 -141 2,925 3,301 3,327 2,277 2,277     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   538 636 771 505 856 2,056 0.0 0.0   Gross profit growth   -2.0% 18.1% 21.2% -34.5% 69.6% 140.2% -100.0% 0.0%   Employees   1 1 1 1 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 200.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   185 146 267 3,771 3,695 3,471 2,200 2,200   Balance sheet change%   -26.2% -21.0% 82.7% 1,310.6% -2.0% -6.0% -36.6% 0.0%   Added value   75.5 73.3 137.5 -68.6 -350.3 858.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -57 -82 -29 3,490 -352 -603 -1,044 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.0% 0.8% 10.7% -18.3% -43.7% 25.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.9% 4.6% 39.7% -4.5% -9.7% 14.2% 0.0% 0.0%   ROI %   34.6% 8.6% 78.4% -5.0% -10.9% 15.8% 0.0% 0.0%   ROE %   24.7% 2.0% 64.7% -7.7% -16.3% 14.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   44.8% 57.8% 42.8% -0.9% -6.2% 0.6% -3.4% -3.4%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -55.8% -49.6% -102.5% -4,265.0% -5,009.8% 387.8% 0.0% 0.0%   Gearing %   2.8% 7.9% 3.6% -8,542.6% -1,363.1% 15,541.8% -2,970.8% -2,970.8%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   32.7% 106.4% 16.8% 6.5% 6.2% 7.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.5 2.1 1.5 0.3 0.1 0.2 0.0 0.0   Current Ratio   1.5 2.1 1.5 0.3 0.1 0.2 0.0 0.0   Cash and cash equivalent   44.4 43.0 145.0 7.2 1.3 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   51.2 66.6 69.7 -480.1 -883.1 -585.2 -1,138.3 -1,138.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   75 73 138 -69 -117 286 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   75 73 138 -69 -22 286 0 0   EBIT / employee   33 5 82 -92 -125 175 0 0   Net earnings / employee   18 2 64 -149 -203 88 0 0